IBDEI0QO ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13117,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13117,1,1,0)
 ;;=1^421.9
 ;;^UTILITY(U,$J,358.3,13117,1,2,0)
 ;;=2^ENDOCARDITIS
 ;;^UTILITY(U,$J,358.3,13117,2)
 ;;=^269701
 ;;^UTILITY(U,$J,358.3,13118,0)
 ;;=422.90^^78^818^9
 ;;^UTILITY(U,$J,358.3,13118,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13118,1,1,0)
 ;;=1^422.90
 ;;^UTILITY(U,$J,358.3,13118,1,2,0)
 ;;=2^MYOCARDITIS
 ;;^UTILITY(U,$J,358.3,13118,2)
 ;;=^269702
 ;;^UTILITY(U,$J,358.3,13119,0)
 ;;=728.86^^78^818^10
 ;;^UTILITY(U,$J,358.3,13119,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13119,1,1,0)
 ;;=1^728.86
 ;;^UTILITY(U,$J,358.3,13119,1,2,0)
 ;;=2^NECROTIZING FASCIITIS
 ;;^UTILITY(U,$J,358.3,13119,2)
 ;;=^303314
 ;;^UTILITY(U,$J,358.3,13120,0)
 ;;=730.20^^78^818^11
 ;;^UTILITY(U,$J,358.3,13120,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13120,1,1,0)
 ;;=1^730.20
 ;;^UTILITY(U,$J,358.3,13120,1,2,0)
 ;;=2^OSTEOMYELITIS NOS-UNSPEC
 ;;^UTILITY(U,$J,358.3,13120,2)
 ;;=^87108
 ;;^UTILITY(U,$J,358.3,13121,0)
 ;;=420.90^^78^818^12
 ;;^UTILITY(U,$J,358.3,13121,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13121,1,1,0)
 ;;=1^420.90
 ;;^UTILITY(U,$J,358.3,13121,1,2,0)
 ;;=2^PERICARDITIS
 ;;^UTILITY(U,$J,358.3,13121,2)
 ;;=^269692
 ;;^UTILITY(U,$J,358.3,13122,0)
 ;;=481.^^78^818^13
 ;;^UTILITY(U,$J,358.3,13122,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13122,1,1,0)
 ;;=1^481.
 ;;^UTILITY(U,$J,358.3,13122,1,2,0)
 ;;=2^PNEUMONIA,PNEUMOCOCCAL
 ;;^UTILITY(U,$J,358.3,13122,2)
 ;;=^95612
 ;;^UTILITY(U,$J,358.3,13123,0)
 ;;=480.0^^78^818^14
 ;;^UTILITY(U,$J,358.3,13123,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13123,1,1,0)
 ;;=1^480.0
 ;;^UTILITY(U,$J,358.3,13123,1,2,0)
 ;;=2^PNEUMONIA,VIRAL
 ;;^UTILITY(U,$J,358.3,13123,2)
 ;;=^269928
 ;;^UTILITY(U,$J,358.3,13124,0)
 ;;=486.^^78^818^15
 ;;^UTILITY(U,$J,358.3,13124,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13124,1,1,0)
 ;;=1^486.
 ;;^UTILITY(U,$J,358.3,13124,1,2,0)
 ;;=2^PNEUMONIA, ORGANISM NOS
 ;;^UTILITY(U,$J,358.3,13124,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,13125,0)
 ;;=038.9^^78^818^16
 ;;^UTILITY(U,$J,358.3,13125,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13125,1,1,0)
 ;;=1^038.9
 ;;^UTILITY(U,$J,358.3,13125,1,2,0)
 ;;=2^SEPSIS
 ;;^UTILITY(U,$J,358.3,13125,2)
 ;;=^109318
 ;;^UTILITY(U,$J,358.3,13126,0)
 ;;=995.90^^78^818^17
 ;;^UTILITY(U,$J,358.3,13126,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13126,1,1,0)
 ;;=1^995.90
 ;;^UTILITY(U,$J,358.3,13126,1,2,0)
 ;;=2^SYSTEM INFLAM RESPONSE SYNDROM
 ;;^UTILITY(U,$J,358.3,13126,2)
 ;;=^328611
 ;;^UTILITY(U,$J,358.3,13127,0)
 ;;=136.9^^78^818^18
 ;;^UTILITY(U,$J,358.3,13127,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13127,1,1,0)
 ;;=1^136.9
 ;;^UTILITY(U,$J,358.3,13127,1,2,0)
 ;;=2^OTH INFECTIOUS CONDITIONS
 ;;^UTILITY(U,$J,358.3,13127,2)
 ;;=^123934
 ;;^UTILITY(U,$J,358.3,13128,0)
 ;;=V71.89^^78^819^1
 ;;^UTILITY(U,$J,358.3,13128,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13128,1,1,0)
 ;;=1^V71.89
 ;;^UTILITY(U,$J,358.3,13128,1,2,0)
 ;;=2^OBSERV OTH SPEC SUSPEC COND
 ;;^UTILITY(U,$J,358.3,13128,2)
 ;;=^322082
 ;;^UTILITY(U,$J,358.3,13129,0)
 ;;=99201^^79^820^1
 ;;^UTILITY(U,$J,358.3,13129,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13129,1,1,0)
 ;;=1^Problem Focus
 ;;^UTILITY(U,$J,358.3,13129,1,2,0)
 ;;=2^99201
 ;;^UTILITY(U,$J,358.3,13130,0)
 ;;=99202^^79^820^2
 ;;^UTILITY(U,$J,358.3,13130,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13130,1,1,0)
 ;;=1^Expanded Problem Focus
 ;;^UTILITY(U,$J,358.3,13130,1,2,0)
 ;;=2^99202
 ;;^UTILITY(U,$J,358.3,13131,0)
 ;;=99203^^79^820^3
 ;;^UTILITY(U,$J,358.3,13131,1,0)
 ;;=^358.31IA^2^2
